Market revenue in 2021 | USD 59.2 million |
Market revenue in 2030 | USD 449.7 million |
Growth rate | 25.3% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.14% in 2021. Horizon Databook has segmented the France ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
France followed Germany with market share of 15.2% in 2020. This growth can be attributed to various strategic initiatives undertaken by market players in France. In addition, growing adoption of technologically advanced solutions for clinical trials and growing number of companies in AI domain are some of the other factors supporting market growth in the country.
Furthermore, Owkin is yet another French company developing AIbased tools and solutions for better clinical research, collaborative clinical trials, and much more. Hence, rising number of companies providing AI-based clinical trial solutions is anticipated to boost market growth in the coming years.
Moreover, favorable funding scenario in the country is responsible for development of dynamic startup scenario in France. Therefore, growing funding along with increasing adoption of technologically advanced solutions is expected to promote growth of AI-based clinical trials solution providers market in France during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the France ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into France ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account